Raub Brock Capital Management LP Acquires 1,123 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Posted by Defense World Staff on Jul 3rd, 2023

Raub Brock Capital Management LP raised its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 2.7% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 43,317 shares of the healthcare conglomerate’s stock after acquiring an additional 1,123 shares during the quarter. UnitedHealth Group makes up 3.9% of Raub Brock Capital Management LP’s portfolio, making the stock its 13th largest holding. Raub Brock Capital Management LP’s holdings in UnitedHealth Group were worth $20,471,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of UNH. Moneta Group Investment Advisors LLC increased its stake in UnitedHealth Group by 100,076.4% in the 4th quarter. Moneta Group Investment Advisors LLC now owns 11,823,820 shares of the healthcare conglomerate’s stock worth $6,268,753,000 after buying an additional 11,812,017 shares in the last quarter. Norges Bank bought a new stake in UnitedHealth Group during the 4th quarter valued at approximately $5,210,004,000. Arrowstreet Capital Limited Partnership boosted its stake in UnitedHealth Group by 1,682.4% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,691,542 shares of the healthcare conglomerate’s stock worth $1,372,606,000 after purchasing an additional 2,540,538 shares during the period. Morgan Stanley raised its position in shares of UnitedHealth Group by 13.8% during the fourth quarter. Morgan Stanley now owns 15,635,038 shares of the healthcare conglomerate’s stock valued at $8,289,386,000 after buying an additional 1,893,192 shares during the last quarter. Finally, Proficio Capital Partners LLC grew its stake in UnitedHealth Group by 45,377.9% during the first quarter. Proficio Capital Partners LLC now owns 1,499,408 shares of the healthcare conglomerate’s stock valued at $1,499,000 after acquiring an additional 1,496,111 shares in the last quarter. 92.61% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on the company. Oppenheimer restated an “outperform” rating and set a $610.00 price objective on shares of UnitedHealth Group in a research report on Monday, April 17th. Deutsche Bank Aktiengesellschaft reduced their price objective on UnitedHealth Group from $627.00 to $564.00 in a research note on Friday, June 16th. TD Cowen cut their target price on shares of UnitedHealth Group from $596.00 to $562.00 and set an “outperform” rating for the company in a report on Monday, April 17th. Raymond James reiterated a “strong-buy” rating and set a $630.00 price objective on shares of UnitedHealth Group in a research report on Friday, April 14th. Finally, StockNews.com cut shares of UnitedHealth Group from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, June 14th. One analyst has rated the stock with a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, UnitedHealth Group has a consensus rating of “Buy” and an average target price of $592.68.

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $480.64 on Monday. The firm has a 50-day moving average of $483.72 and a two-hundred day moving average of $489.73. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.81 and a quick ratio of 0.81. UnitedHealth Group Incorporated has a 1 year low of $445.68 and a 1 year high of $558.10. The stock has a market cap of $447.49 billion, a price-to-earnings ratio of 21.98, a price-to-earnings-growth ratio of 1.41 and a beta of 0.66.

UnitedHealth Group (NYSE:UNH – Free Report) last issued its earnings results on Friday, April 14th. The healthcare conglomerate reported $6.26 earnings per share for the quarter, beating analysts’ consensus estimates of $6.24 by $0.02. UnitedHealth Group had a return on equity of 27.05% and a net margin of 6.16%. The business had revenue of $91.93 billion during the quarter, compared to analyst estimates of $89.77 billion. During the same period in the previous year, the company posted $5.49 EPS. UnitedHealth Group’s revenue was up 14.7% on a year-over-year basis. On average, research analysts forecast that UnitedHealth Group Incorporated will post 24.86 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 27th. Investors of record on Monday, June 19th were paid a $1.88 dividend. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.65. The ex-dividend date of this dividend was Thursday, June 15th. This represents a $7.52 dividend on an annualized basis and a yield of 1.56%. UnitedHealth Group’s payout ratio is 34.39%.

Insider Buying and Selling at UnitedHealth Group

In related news, EVP Erin Mcsweeney sold 1,684 shares of the firm’s stock in a transaction dated Monday, April 24th. The stock was sold at an average price of $488.46, for a total transaction of $822,566.64. Following the sale, the executive vice president now owns 8,675 shares of the company’s stock, valued at $4,237,390.50. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In other news, CEO Andrew Witty sold 6,160 shares of the stock in a transaction on Thursday, April 27th. The stock was sold at an average price of $487.49, for a total transaction of $3,002,938.40. Following the completion of the sale, the chief executive officer now owns 86,564 shares in the company, valued at approximately $42,199,084.36. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, EVP Erin Mcsweeney sold 1,684 shares of the company’s stock in a transaction dated Monday, April 24th. The shares were sold at an average price of $488.46, for a total value of $822,566.64. Following the transaction, the executive vice president now directly owns 8,675 shares in the company, valued at $4,237,390.50. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 8,852 shares of company stock valued at $4,313,962. 0.35% of the stock is currently owned by corporate insiders.

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.